Nine Chapters Capital Management LLC purchased a new stake in shares of Cigna Corporation (NYSE:CI) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,200 shares of the health services provider’s stock, valued at approximately $224,000.

Several other hedge funds have also recently added to or reduced their stakes in CI. Spot Trading L.L.C. lifted its position in shares of Cigna Corporation by 108.9% during the first quarter. Spot Trading L.L.C. now owns 1,998 shares of the health services provider’s stock valued at $293,000 after buying an additional 24,425 shares during the last quarter. Oppenheimer & Co. Inc. raised its position in shares of Cigna Corporation by 26.7% in the 1st quarter. Oppenheimer & Co. Inc. now owns 10,115 shares of the health services provider’s stock valued at $1,482,000 after purchasing an additional 2,132 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new position in shares of Cigna Corporation in the 1st quarter valued at approximately $1,456,000. PEAK6 Investments L.P. raised its position in shares of Cigna Corporation by 128.5% in the 1st quarter. PEAK6 Investments L.P. now owns 6,592 shares of the health services provider’s stock valued at $966,000 after purchasing an additional 29,692 shares during the last quarter. Finally, Two Sigma Securities LLC raised its position in shares of Cigna Corporation by 121.6% in the 1st quarter. Two Sigma Securities LLC now owns 3,926 shares of the health services provider’s stock valued at $575,000 after purchasing an additional 2,154 shares during the last quarter. 88.23% of the stock is owned by institutional investors and hedge funds.

Cigna Corporation (NYSE:CI) last issued its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.36 by $0.47. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The company had revenue of $10.38 billion during the quarter, compared to analysts’ expectations of $10.17 billion. During the same quarter in the previous year, the business earned $1.94 earnings per share. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis.

COPYRIGHT VIOLATION WARNING: This story was reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://www.watchlistnews.com/nine-chapters-capital-management-llc-takes-224000-position-in-cigna-corporation-ci/1675857.html.

In other news, Director William D. Zollars sold 1,232 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total transaction of $230,667.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jason D. Sadler sold 37,756 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $176.16, for a total value of $6,651,096.96. Following the sale, the insider now owns 47,844 shares of the company’s stock, valued at approximately $8,428,199.04. The disclosure for this sale can be found here. Insiders have sold 45,696 shares of company stock valued at $8,070,481 in the last 90 days. Company insiders own 1.30% of the company’s stock.

Several equities analysts recently commented on CI shares. Deutsche Bank AG increased their price objective on shares of Cigna Corporation from $180.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, August 7th. Credit Suisse Group reaffirmed a “buy” rating and issued a $196.00 price objective on shares of Cigna Corporation in a research report on Friday, August 4th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $190.00 price objective (down from $199.00) on shares of Cigna Corporation in a research report on Friday, August 4th. BidaskClub lowered shares of Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $175.00 price objective on shares of Cigna Corporation in a research report on Friday, July 28th. Two research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $197.06.

Cigna Corporation Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.